IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
From the first launch to ongoing market access execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We are the data and application backbone for market access departments of Life Sciences manufacturers, enabling them to accelerate their commercialization process, digitalize their operations, and get therapies to patients faster.
Solutions overview
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Learn how Integrichain helps pharma manufacturing companies develop a strong drug commercialization and launch strategy that addresses market access challenges from the start.
The idea of having a unified platform through a single vendor was so important to us leading up to launch.
Senior Vice President | Finance
Manufacturers that successfully implement a well-defined drug commercialization and launch plan are more likely to attain their revenue goals and outperform the competition in their go-to-market strategy. Pre-commercial manufacturers in particular have the unique opportunity to place the patient at the center of their commercial strategy using coordinated, intelligent engagement with guidance from our professional service teams.
Having supported more than 70% of new life science product launches in the US over the past three years, we know the formula:
Pre-launch insights into competitive market baskets, pricing and contracting scenarios, and financial modeling guide the path to launch
Government pricing compliance and commercial contracts are in place and maximized for value
Data-Driven Gross-to-Net systems are prepared for modeling and forecasting
Channel is developed and ready to maintain access to product
Patient access roadblocks are defined, with solutions for resolution
IntegriChain’s ICyte platform and advisory services help solve these launch readiness challenges with a fully-integrated and scalable approach. New and emerging life science manufacturers will benefit from our launch readiness solutions with a faster, smoother drug commercialization process.
Learn more about ICyte
We are experts in launch readiness.
We deliver expert advisory services on pricing, contracts, and gross-to-net combined with data, analytics, and managed services that adapt to changing demands across your brand’s life cycle.
Launch Timeline Specialty Launch Checklist Drug Commercialization 101 Infographic
